Timothy P. Cooley

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

Lawrence D. Kaplan, David J. Straus, Marcia A. Testa et al. · New England Journal of Medicine · 1997 · 378 citations · Full text

Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex

Timothy P. Cooley, Laureen M. Kunches, Carol A. Saunders et al. · New England Journal of Medicine · 1990 · 254 citations

Immunodeficiencies, Immunology, Pharmacotherapy +17

Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)

Kwan Kew Lai, David L. Gang, John K. Zawacki et al. · Annals of Internal Medicine · 1991 · 161 citations

Immunodeficiencies, Immunology, Gastroenterology +26

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.

Bruce J. Dezube, Jamie H. Von Roenn, Jeanne Holden‐Wiltse et al. · Journal of Clinical Oncology · 1998 · 130 citations

Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex

Mark A. Wainberg, Horacio Salomón, Zhengxian Gu et al. · AIDS · 1995 · 109 citations